I. Bonnacker

Most-cited papers

1. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS

   I. Maev, Yury A. Kucheryavyy, N. Gubergrits, I. Bonnacker +3 more

   2020Drugs in R&D18 citations Open access

   Semantic Scholar

   Save

2. Numerical stability of pharmacokinetic deconvolution algorithms.

   R. Süverkrüp, I. Bonnacker, H. Raubach

   1989Journal of Pharmacy and Science9 citations

   Semantic Scholar

   Save

3. Renal clearance of theophylline and its major metabolites: Age and urine flow dependency in paediatric patients

   I. Bonnacker, D. Berdel, R. Süverkrüp, A. Berg

   2004European Journal of Clinical Pharmacology4 citations

   Semantic Scholar

   Save

4. Author’s Reply to Petersen: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”

   I. Maev, Yury A. Kucheryavyy, N. Gubergrits, I. Bonnacker +3 more

   2021Drugs in R&D0 citations Open access

   Semantic Scholar

   Save

5. Counter racemization stabilized pharmaceutical preparations of cilansetron

   I. Bonnacker, H. Koehn, G. Kristen, C. Reichel

   19980 citations

   Semantic Scholar

   Save

6. Pharmaceutical preparations of cilansetron against racemization stabilized

   I. Bonnacker, G. Kristen, H. Koehn, C. Reichel

   19980 citations

   Semantic Scholar

   Save

7. A stabilized pharmaceutical composition comprising dopamine or dobutamine

   I. Bonnacker, Wolfgang Toelke, M. Lerch

   19970 citations

   Semantic Scholar

   Save

8. Orally administered Metoclopramidlösungen

   I. Bonnacker, R. Klimek, B. Stemmle

   19910 citations

   Semantic Scholar

   Save

9. [Bioequivalence of theophylline retard capsules in children and relation of metabolism to administration route].

   D. Berdel, I. Bonnacker, R. Süverkrüp, A. Vonberg +1 more

   1990Pneumologie0 citations

   Semantic Scholar

   Save